Objective: To evaluate the impact of the introduction of the heptavalent pneumococcal conjugate vaccine (PCV-7) in the management of children aged 6 to 24 months with high fever without source (FWS) in a pediatric emergency department (PED). Methods: Retrospective study of 770 patients aged 6 to 24 months attended in a pediatric ED between October 2004 and April 2005 with FWS 398C or higher without alteration in the dipstick. Results: Out of 770 children, 215 (27.9%) were PCV-7 fully vaccinated (group A), and 555 (72.0%) were either incompletely PCV-7 vaccinated or not vaccinated at all (group B). Both groups did not show differences related to temperature registered at home or in the ED. Complete blood count (CBC) and blood culture were practiced in 163 (21.1%) patients, chest radiograph in 117 (15.1%), and lumbar puncture in 15 (1.9%). Thirty-three patients (4.3%) received a dose of intramuscular ceftriaxone, 20 (2.6%) were admitted to the observation unit, and 5 (0.6) were admitted to the hospital. One blood culture was positive, and 2 other children had a consolidation in the chest radiograph (all in group B). In patients not fully vaccinated with PCV-7, CBC and blood culture were practiced more frequently (group B, 26.6% vs. group A, 7%; P < 0.000001; odds ratio, 4.85 [limits, 2.70-8.83]) and ceftriaxone was also more frequently administered (group B, 5.3% vs. group A, 1.3%; P = 0.02; odds ratio, 4.04 [limits, 1.16 -16.77]). Three children in group A (1.4%) were admitted to the observation unit or to floor versus 22 in group B (4%, P = 0.11). Conclusions: Inclusion of PCV-7 vaccinal status in the management of highly febrile children aged 6 to 24 months significantly reduces CBC and blood cultures practiced in the ED and the administration of ceftriaxone.
F ever is the most common reason for healthy young children to visit a pediatric emergency department (ED) in the area covered by our hospital. 1 Most of the time, these infants have fever without source (FWS), usually they come straight away to the pediatric ED and often have either viral or minor bacterial infections, and recover uneventfully, although occasionally they can present potentially severe bacterial infections. 2 -5 The most frequent severe bacterial infections in those infants with FWS is the urinary tract infection, whereas the incidence of occult bacteremia, mainly by pneumococcus, in well-appearing infants with fever higher than 398C varies usually around 2%. Although occult bacteremia caused by pneumococcus is at times self limited, around 2% to 5% of all infants will develop a serious bacterial infection such as meningitis. 6, 7 One of the challenges which pediatricians face is to identify those highly febrile infants at risk for occult bacteremia. 3 Bacteremia is usually associated with high temperatures, elevated total white blood cell count and elevated absolute neutrophil count, but even so, the yield of the laboratory tests is low.
The incidence of pneumococcal invasive infections (such as meningitis) and bacteremia has drastically diminished in populations vaccinated with the PCV-7. 8 -11 In this way, some authors defend not to practice CBC and blood culture in the well-appearing previously healthy infant who consult with FWS, and have received at least 1 dose, 2 doses, or a whole PCV-7 vaccination.
2,11 -14 The PCV-7 was licensed in Spain in 2000, and the immunization rate in infants attended in EDs is progressively increasing. 15 In our pediatric ED, the decision to practice CBC and blood culture in these children depended on their temperature, age, and time of evolution of the process. 15 On September 2004, we included the PCV-7 in the management of children aged 6 to 24 months with FWS higher than 398C. In this way, in children not fully vaccinated with PCV-7, we strongly recommended the practice of CBC and blood culture. However, a child who was fully vaccinated was considered to be at low risk for pneumococcal invasive infection or bacteremia and, therefore, laboratory tests only need to be occasionally performed.
The objective of this study is to evaluate the impact of the introduction of the PCV-7 vaccinal status in the management of children aged 6 to 24 months with high FWS in a pediatric ED.
METHODS
Retrospective study of 770 patients aged 6 to 24 months attended in our pediatric ED between October 2004 and April 2005 with FWS 398C or higher without alteration in the dipstick (leukocyturia or nitrituria).
Demographic data, PCV vaccinal status, complementary tests practiced, applied treatments, received diagnosis, destination of the children, and unscheduled revisits to the ED were registered.
Definitions are as follows: FWS: axillary or rectal registry at home or rectal registry in the pediatric ED of a temperature 388C or higher, without catarrhal or respiratory symptoms/signs (such as tachypnea), or a diarrheal process in a patient with a normal physical examination (no signs of acute otitis media, or osteoarticular or soft tissue infection; and normal pulmonary auscultation); Occult bacteremia: febrile process in well-appearing children where the growth of pathogenic bacteria is detected in their blood; and We considered fully PCV-7 vaccinal status when they have the following characteristics:
Infants aged 6 to 12 months received 3 doses of PCV-7, the last one at least 15 days before coming to the ED; or Infants aged 12 to 24 months who have the following characteristics: Infants who received 3 doses of PCV-7 administered during the first year of life; or Infants who received 2 doses of PCV-7, if the first was given after 12 months of age and the last one at least 15 days before coming to the ED. Inclusion criterion: Infants aged 6 to 24 months with FWS 398C or more.
Exclusion criteria: Immunodeficiency; Infants with abnormalities in the urine dipstick (leukocyturia or nitrituria) when practiced. In these patients, we routinely perform CBC and blood culture; and Patients in which the anamnesis and/or the physical examination allowed to identify the origin of the fever, specifically those children diagnosed according to the diagnosis codification of the Spanish Society of Paediatric Emergencies:
Upper respiratory tract infection: catarrhal process with or without fever, which affects the upper respiratory tract and causes rhinorrhea, mucosal hyperemia, and/or irritative cough; and Acute gastroenteritis: increase of the daily volume of depositions with increase of the frequency and liquidity of them, associated or not with vomits and/or fever.
RESULTS
Between October 15, 2004 and April 7, 2005 , 1111 episodes corresponding to children aged 6 to 24 months with FWS were registered in the pediatric ED (Table 1) . Of these, 770 had fever 398C or more registered at home or in the pediatric ED and did not show alterations in urine dipstick.
The 772 children were classified into 2 groups: group A: children who were fully vaccinated with PCV-7 (n = 215 [27.9%]); and group B: children with no dose of PCV-7 or incompletely vaccinated (n = 555 [72.0%]). Of these, 175 had received at least 1 dose of PCV-7, and 380 had received no dose.
Patient Characteristics
There were no differences in the temperature of both groups. Sex distribution was similar. The mean age of group A patients (15.6 ± 4.4 months) was higher than that of group B patients (11.8 ± 5.1 months, P < 0.001).
Tests Practiced in ED
CBC and blood culture were practiced in 163 patients (21.1%), chest radiographs in 117 (15.1%), and lumbar puncture in 15 (1.9%). Thirty-three patients (4.3%) received intramuscular ceftriaxone.
One blood culture obtained at the time of evaluation yielded a pathogen, pneumococcus (a 21-month-old infant who had not received any dose of PCV-7) and 2 children had a consolidation in the chest radiograph (an 11-month-old boy who had received 2 doses of PCV-7 and a 15-month-old boy who had not received any dose of PCV-7).
In group B, CBC and blood culture were practiced in 148 patients (26.6% vs. 15 patients in group A [7%]; P < 0.000001; odds ratio, 4.85 [limits, 2.70 -8.83]). Among patients in group B, CBC and blood culture were practiced more frequently in those who had not received any dose of VCN (29.5% vs. 20.6% of those who received at least 1 dose of PCV-7 but were considered not fully vaccinated, P = 0.003).
Chest radiograph was practiced in 25 children (11.6%) in group A and 92 (16.6%, P = 0.1) in group B. Lumbar puncture was practiced in 3 children (1.4%) in group A and in 12 (2.2%) in group B (P = 0.35).
In group B, 30 children (5.4%) received intramuscular ceftriaxone versus 3 (1.3%; P = 0.02; odds ratio, 4.04 [limits, The average stay in the ED was similar in both groups (group A, 131 ± 72 minutes; group B, 136 ± 78 minutes; P = 0.38), excluding patients admitted to floor or to the observation unit.
Patient Destination
A total of 745 patients (96.8%) were sent home, 20 (2.6%) were admitted into the observation unit, and 5 (0.6%) in floor.
In group A, 3 (1.4%) children were admitted versus 22 (4%, P = 0.11) in group B. In group B, those children who had not received any dose of PCV-7 were admitted more frequently that those with at least 1 dose of PCV-7 (5.3% vs. 1.1%, P = 0.03).
Around 13% of patients revisited the ED (similar percentage in both groups).
DISCUSSION
To our knowledge, this is the first study to evaluate the impact of the PCV-7 in the management of highly febrile children aged 6 to 24 months in a pediatric ED.
The management of the well-appearing, previously healthy infant with FWS remains one of the most controversial issues in pediatric emergency medicine. 2, 3, 12, 13, 16 Usually, these children have self-limited viral processes although, occasionally, potentially severe bacterial infections could be present.
In the past, appropriate management of children between 2 and 36 months of age with high FWS included obtaining CBC and blood culture. Empirical antibiotic therapy was administered to those patients with a white blood cell count greater than 15,000/mL. This was caused by the fact that this criterion defined a subgroup of febrile children at increased risk for occult bacteremia. 3 The incidence of occult bacteremia in the pre -PCV-7 era varied around 2% being pneumococcus responsible for approximately 90% of the cases. With these rates of bacteremia, the most cost-effective strategy for the management of these patients seems to be performing CBC and, when appropriate, blood culture, and treatment. 17 The use of PCV-7 has meant a dramatic reduction in pneumococcal invasive infections (meningitis) and bacteremia, specially in children aged less than 2 years. 8 -11 As a matter of fact, many authors recommend a different management in those children with 1 dose, 2 doses, or a whole PCV-7 vaccination. 2,11 -14 However, other authors continue to recommend that PCV-7 vaccination should not be taken into consideration when managing infants with FWS. 16 The introduction of PCV-7 seems to be changing the physicians' attitudes toward the management of young febrile children. In this way, pediatricians and ED physicians would order fewer CBC counts and blood cultures and administer less empirical ceftriaxone if a child was vaccinated with PCV-7. 18, 19 On September 2004, our pediatric ED started including the PCV-7 in the management of children aged 6 to 24 months with FWS higher than 398C. This way, if a child is not fully vaccinated, we strongly recommended the practice of CBC and blood culture. A fully vaccinated child is considered to be at low risk for pneumococcal invasive infection or bacteremia, and laboratory tests should only be performed occasionally.
Our study reflects that the introduction of the PCV-7 in the management of children aged 6 to 24 months has meant substantial changes in the management approach for these children in the ED. This way, the percentage of patients in which CBC and blood culture were practiced and those who receive intramuscular ceftriaxone has significantly decreased.
Even cost-effectiveness studies seem to indicate that if the expected reduction of the bacteremia rate goes below 0.5%, thanks to the generalization of the PCV-7, the practice of CBC and blood culture will not be useful in the management of these patients. 17 Indirect benefits of routine vaccination (herd-immunity) resulting in decreased transmission to nonimmunized children and adults should support this fact. 20 On the other hand, geographic variations in pneumococcal serotypes causing bacteremia have to be considered. 21 Ongoing surveillance is needed to assess whether reductions in vaccine-serotype invasive pneumococcal disease are sustained, and whether replacement disease will limit the substantial benefits of routine vaccination.
Our study also reflects pediatricians' low compliance with the management guidelines for infants with FWS. Despite our strong recommendation to practice CBC and blood culture in children with no PCV-7 or incomplete vaccination, tests were only practiced in one fourth of the children. Emergency pediatricians managed children with incomplete vaccination differently from those who had not received any dose of PCV-7, even though there is no specific mention in our protocol. These differences in the management approach of the child with FWS and the pediatricians' poor compliance with the protocols have already been reported in previous literature. 22, 23 However, we do not consider that the reduction of tests performed and administered antibiotics in fully vaccinated children is a result of these.
Our study has some limitations. The fact that it is a retrospective study limits the collection of data. Nevertheless, a retrospective study like this one may have an advantage, as it does not influence the practice patterns of the emergency pediatricians. On the other hand, a prospective study would have allowed a better follow-up of the patients.
CONCLUSIONS
We can affirm that the inclusion of PCV-7 in the management children aged 6 to 24 months with FWS higher than 398C reduces significantly the CBC and blood cultures practiced in the ED and the administration of ceftriaxone.
